semaglutide essence in MASH with F2-F3 fibrosis: a holistic perspective on the phase 3 trial Semaglutide Receives FDA Approval for

Commercial GLP-1 Agonists Commercially available GLP-1 agonists are prescription therapies commonly used to support blood sugar management and weight management in appropriate patients

The authors identify an anti-adipogenic population that may inhibit adipocyte differentiation in vitro

Is dehydration a real concern with Ozempic

Oral glucagon-like peptide-1 receptor agonists and combinations of enteropancreatic hormones as treatments for adults with type 2 diabetes: where are we now

It works by mimicking a hormone in the body that helps regulate appetite, digestion, and blood sugar levels

Lipid effects were generally neutral